Coupé, Veerle M H <br/><br/>
Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.  [electronic resource] 

 -  Journal of the National Cancer Institute  Mar 2010 
 - 358; author reply 358 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djp372  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alphapapillomavirus--immunology<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Female<br/>Humans<br/>Netherlands<br/>Papillomavirus Infections--economics<br/>Papillomavirus Vaccines--administration & dosage<br/>Quality-Adjusted Life Years<br/>Tumor Virus Infections--economics